Laparoskopik nefrektomide yatış süresini etkileyen faktörler: Tek Merkez 330 Vaka Deneyimi

Amaç: Bu çalışmamızda laparoskopik nefrektomi yapılan hastalarda yatış süresini etkileyen faktörleri araştırmayı amaçladık. Materyal ve metot: Ocak 2013-Aralık 2021 tarihleri arasında kliniğimizde laparoskopik nefrektomi yapılan hastaların verileri retrospektif olarak incelendi. Hastaların demografik verileri, preoperatif, peroperatif ve postoperatif özellikleri kaydedildi. Çalışmaya dahil edilen hastalar yatış süresi ≤4 gün ve >4 gün olarak iki gruba ayrıldı. Gruplar arasında demografik özellikler, operasyon verileri, peroperatif ve postoperatif komplikasyon durumu univariate analiz ile karşılaştırılarak yatış süresinin uzaması açısından olası risk faktörleri değerlendirildi. Bulgular: Çalışmaya kliniğimizde laparoskopik nefrektomi yapılan 330 hasta dahil edildi. Hastaların 130’u (%39.3) kadın, 200’ü (%60.7) erkek ve ortalama yaşı 50.8±19.7 idi. Hastaların 220’sinin (%66.7) ≤4 gün, 110’unun (%33.3) ise 4 günden uzun yattığı görüldü. Operasyon süresinin uzun olduğu hastalarda yatış süresi de buna paralel olarak uzundu (p

Efficacy and safety of percutaneous nephrolithotomy in elderly patients: Experience of 128 cases

OBJECTIVE: This study aimed to evaluate the efficacy and safety of percutaneous nephrolithotomy in elderly patients (≥65 years) with kidney stones > 2 cm in size. PATIENTS AND METHODS: Patients aged ≥65 years who underwent percutaneous nephrolithotomy for kidney stones between January 2015 and January 2022 were included in this study. Patient profiles, preoperative stone data, operative information, and postoperative complications were reviewed. We applied the Guys Stone score to predict the net results of percutaneous nephrolithotomy. RESULTS: Percutaneous nephrolithotomy was performed on 128 geriatric patients. Of these patients, 68 (53.1%) were male and 60 (46.9%) were female. The mean age was 69.87 ± 7.06 (65–80) years. The mean stone size was 28.7 ± 6.5 mm (22–46 mm). The mean operative time was 90.33 ± 40.56 min and fluoroscopy time was 5.16 ± 2.81 min. The reentry catheter was removed after an average of 3.21 ± 1.82 days. The mean duration of hospital stay was 3.17 ± 2.19 days. The stone-free survival rate was 90.6%. Transfusion was performed in four (3.1%) patients due to hemorrhage, and urine extravasation from the re-entry tract occurred in eight (6.2%) patients, and this required Double j-stent placement. When the four Guys stone score groups were compared, there was a statistically significant difference in stone-free rates (p = 0.001). CONCLUSIONS: According to our results, percutaneous nephrolithotomy is a safe and effective treatment option for nephrolithiasis in the elderly, with high stone-free and acceptable complication rates.

___

  • 1. Clayman RV, Kavoussi LR, Soper NJ, et al. La- paroscopic nephrectomy: initial case report. J Urol. 1991;146:278-82. doi: 10.1016/s0022-5347(17)37770-4
  • 2. Siqueira JR TM, Kuo RL, Gardner TA, et al. Ma- jor complications in 213 laparoscopic nephrec- tomy cases: the Indianapolis experience. J Urol. 2002;168:1361-5. doi: 10.1097/01.ju.0000023288.55478.42
  • 3. Kerbl K, Clayman RV, McDougall EM, et al. Transperitoneal nephrectomy for benign disease of the kidney: a comparison of laparoscopic and open surgical techniques. Urology. 1994;43:607- 13. doi: 10.1016/0090-4295(94)90171-6
  • 4. Wilson BG, Deans GT, Kelly J, et al. Laparosco- pic nephrectomy: initial experience and cost imp- lications. Br J Urol. 1995;75:276-80. doi: 10.1111/j.1464-410x.1995.tb07337.x
  • 5. Fornara P, Doehn C, Friedrich HJ, et al. Nonran- domized comparison of open flank versus lapa- roscopic nephrectomy in 249 patients with be- nign renal disease. Eur Urol. 2001;40:24-31. doi: 10.1159/000049745
  • 6. Gill IS, Clayman RV, McDougall EM. Advances in urological laparoscopy. J Urol. 1995;154:1275-94.
  • 7. Rotter T, Kinsman L, James E, et al. Clinical pathways: effects on professional practice, pati- ent outcomes, length of stay and hospital costs. Cochrane Database Syst Rev. 2010;3:CD006632. doi: 10.1002/14651858.CD006632.pub2
  • 8. Clark DE and Ryan LM. Concurrent prediction of hospital mortality and length of stay from risk factors on admission. Health Serv Res. 2002;37(3):631-45. doi: 10.1111/1475-6773.00041
  • 9. Ingraham AM, Cohen ME, Bilimoria KY, et al. Association of surgical care improvement Project infection-related process measure compli- ance with risk-adjusted outcomes: implications for quality measurement. J Am Coll Surg. 2010;211(6):705-14. doi: 10.1016/j.jamcollsurg.2010.09.006
  • 10. Davenport DL, Henderson WG, Khuri SF, et al. Preoperative risk factors and surgical complexity are more predictive of costs than postoperative complications: a case study using the National Surgical Quality Improvement Program (NSQIP) database. Ann Surg. 2005;242(4):463. doi: 10.1097/01.sla.0000183348.15117.ab
  • 11. Polverejan E, Gardiner JC, Bradley CJ, et al. Es- timating mean hospital cost as a function of length of stay and patient characteristics. Health Econ. 2003;12(11):93547. doi: 10.1002/hec.774
  • 12. Hollenbeck BK, Miller DC, Taub D, et al. Risk factors for adverse outcomes after transurethral resection of bladder tumors. Cancer. 2006;106(7):1527-35. doi: 10.1002/cncr.21765
  • 13. Aronow HD, Peyser PA, Eagle KA, et al. Predic- tors of length of stay after coronary stenting. Am Heart J. 2001;142(5):799-5. doi: 10.1067/mhj.2001.119371
  • 14. Ghali WA, Hall RE, Ash AS, et al. Identifying preand postoperative predictors of cost and length of stay for coronary artery bypass surgery. Am J Med Qual. 1999;14(6):248-54. doi: 10.1177/106286069901400604
  • 15. Wallner LP, Dunn RL, Sarma AV, et al. Risk fac- tors for prolonged length of stay after urologic surgery: the National Surgical Quality Improve- ment Program. J Am Coll Surg. 2008;207(6):904-13. doi: 10.1016/j.jamcollsurg.2008.08.015
  • 16. Dimick JB, Cowan JA, Colletti LM et al: Hospi- tal teaching status and outcomes of complex sur- gical procedures in the United States. Arch Surg 2004; 139(2):137-41. doi: 10.1001/archsurg.139.2.137
  • 17. Jeldres C, Suardi N, Capitanio U, et al. High sur- gical volume is associated with a lower rate of secondary therapy after radical prostatectomy for localized prostate cancer. BJU Int. 2008; 102(4):463-67. doi: 10.1111/j.1464-410X.2008.07705.x
  • 18. Begg CB, Cramer LD, Hoskins WJ, et al. Impact of hospital volume on operative mortality for ma- jor cancer surgery. JAMA. 1998; 280(20):1747- 51. doi: 10.1001/jama.280.20.1747
  • 19. Khuri SF and Henderson WG. The case against volume as a measure of quality of surgical care. World J Surg. 2005; 29(10):1222-29. doi: 10.1007/s00268-005-7987-6
  • 20. Keeler EB, Rubenstein LV, Kahn KL, et al. Hos- pital characteristics and quality of care. JAMA. 1992;268(13):1709-14. doi:10.1001/jama.1992.03490130097037
  • 21. Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002;346(15):1128-37. doi: 10.1056/NEJMsa012337
  • 22. Miller DC, Daignault S, Wolf JS Jr, et al. Hospi- tal characteristics and use of innovative surgical therapies among patients with kidney cancer. Med Care. 2008;46:372-79. doi: 10.1097/MLR.0b013e31816099a7
  • 23. Konety BR, Allareddy V, Modak S, et al. Morta- lity after major surgery for urologic cancers in specialized urology hospitals: are they any bet- ter? J Clin Oncol. 2006;24(13):2006-12. doi: 10.1200/JCO.2005.04.2622
  • 24. Finlayson E, Goodney P and Birkmeyer JD. Hos- pital volume and operative mortality in cancer surgery: a national study. Arch Surg. 2003;138(7):721-25. doi:10.1001/archsurg.138.7.721
  • 25. Cheema IA, Manecksha RP, Murphy M, et al. Laparoscopic nephrectomy: initial experience with 120 cases. Ir Med J. 2010;103:49-51.
  • 26. Dunn MD, Portis AJ, Shalhav AL, et al. Laparos- copic versus open nephrectomy: a 9-year expe- rience. J Urol 2000;164:1153-9.
  • 27. Azawi NH, Christensen T, Petri AL, et al. Pro- longed length of hospital stay in Denmark after nephrectomy. Dan Med J. 2012;59(6):A4446.
Çukurova Anestezi ve Cerrahi Bilimler Dergisi-Cover
  • Yayın Aralığı: Yılda 3 Sayı
  • Başlangıç: 2018
  • Yayıncı: Merthan Tunay
Sayıdaki Diğer Makaleler

Laparoskopik nefrektomide yatış süresini etkileyen faktörler: Tek Merkez 330 Vaka Deneyimi

Kadir KARKİN, Ediz VURUŞKAN

Erişkin Dönemin Nadir Görülen Beyin Tümörü: Medulloblastom Tanılı 28 Hastanın Demografik Özellikleri

Tolga KÖŞECİ, Serdar ATA, Mustafa SEYYAR, Polat OLGUN, Ertuğrul BAYRAM, Kadir ESER, Zeynel Abidin TAŞ

Vertebral Kompresyon Kırıklarının Perkütan Kifoplasti ile Tedavisinde Anestezi Yöntemlerinin Etkinliğinin Karşılaştırılması

Hamide Ayben KORKMAZ, Ahmet KARAOĞLU, İlkay CEYLAN

Multipl Sklerozlu Hastalarda Servikal Spinal Kord Atrofisinin Manyetik Rezonans Görüntüleme ile Değerlendirilmesi:

Mehmet AKÇİÇEK, Mehtap ILGAR, Serkan ÜNLÜ

Ratlarda Rosmarinik Asit’in Akut Pankreatit Üzerindeki Koruyucu Etkinliğinin İncelenmesi

Memet RENCBER, Abdullah OĞUZ, Eda YİLDİZHAN

Kryoballon ile Tek Merkezde Atriyal Fibrilasyon Ablasyonu Deneyimi

Ayhan KÜP, Mehmet ÇELİK, Mehmet ÖZGEYİK, Serdar DEMİR, Kamil GÜLŞEN, Taylan AKGÜN, Abdulkadi USLU

Hemodiyaliz Hastalarında Depresyon ve Yaşam Kalitesi ile İlişkili Faktörler

Engin ONAN, Saime PAYDAS, Bülent KAYA, Tuba KORKMAZ, Ahmet Gazi MUSTAN, Merve SUNGUR ÖZGÜNEN, Farid Mohamad HAMAD, Ertan KARA

Yaşlı hastalarda perkütan nefrolitotominin etkinliği ve güvenilirliği: 128 vaka deneyimi

Kadir KARKİN, Ediz VURUŞKAN

Akut Arteriyel Kanamalarda Transkatater Siyanoakrilat Glue Embolizasyonun Güvenliğinin ve Etkinliğinin Değerlendirilmesi

Bilen ONAN, Hüseyin AKKAYA, Sinan SÖZÜTOK, Ferhat Can PİŞKİN, Ömer KAYA, Tuğsan BALLI

COVID-19 enfeksiyonunda yoğun bakımda BNP'nin prognostik bir biyobelirteç olarak yeniden tanımlanması

Özge TURGAY YILDIRIM, Ayşe AYYILDIZ, Selim YILDIRIM